{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:05:49Z","timestamp":1772247949964,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002808","name":"Carlsbergfondet","doi-asserted-by":"publisher","award":["CF20\u20100045"],"award-info":[{"award-number":["CF20\u20100045"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NFF205A0063505"],"award-info":[{"award-number":["NFF205A0063505"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF20SA0064201"],"award-info":[{"award-number":["NNF20SA0064201"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Factors influencing SARS\u2010CoV\u20102 antibody dynamics, transmission, waning and long COVID\u201019 symptomatology are still not fully understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In the Danish section of the Novo Nordisk Group, we performed a prospective seroepidemiological study during the first and second waves of the COVID\u201019 pandemic. All employees and their household members (&gt;18 years) were invited to participate in a baseline (June\u2013August 2020), 6\u2010month follow\u2010up (December 2020\u2013January 2021), and 12\u2010month follow\u2010up (August 2021) sampling. In total, 18,614 accepted and provided at least one blood sample and completed a questionnaire regarding socioeconomic background, health status, previous SARS\u2010CoV\u20102 infection, and persistent symptoms. Total antibody and specific IgM, IgG and IgA levels against recombinant receptor binding domain were tested.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At baseline, the SARS\u2010CoV\u20102\u2010antibody seroprevalence was 3.9%. At 6\u2010month follow\u2010up, the seroprevalence was 9.1%, while at 12\u2010month follow\u2010up, the seroprevalence was 94.4% (after the vaccine roll\u2010out). Male sex and younger age (18\u201340 years) were significant risk factors for seropositivity. From baseline to the 6\u2010month sampling, we observed a substantial waning of IgM, IgG and IgA levels (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001), regardless of age, sex and initial antibody level. An increased antibody level was found in individuals infected prior to vaccination compared to vaccinated infection na\u00efves (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.0001). Approximately a third of the seropositive individuals reported one or more persistent COVID\u201019 symptoms, with anosmia and\/or ageusia (17.5%) and fatigue (15.3%) being the most prevalent.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The study provides a comprehensive insight into SARS\u2010CoV\u20102 antibody seroprevalence following infection and vaccination, waning, persistent COVID\u201019 symptomatology and risk factors for seropositivity in large working environments.<\/jats:p><\/jats:sec>","DOI":"10.1111\/joim.13637","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T01:09:56Z","timestamp":1680829796000},"page":"763-781","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["SARS\u2010CoV\u20102 antibody dynamics over time and risk factors associated with infection and long COVID\u201019 symptoms in large working environments"],"prefix":"10.1111","volume":"293","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-4522","authenticated-orcid":false,"given":"Cecilie Bo","family":"Hansen","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Medicine Department of Clinical Immunology, Section 7631, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Dvoncova","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine Department of Clinical Immunology, Section 7631, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"P\u00e9rez\u2010Al\u00f3s","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine Department of Clinical Immunology, Section 7631, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamille","family":"Fogh","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Cardiology Herlev and Gentofte Hospital  Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3083-5992","authenticated-orcid":false,"given":"Johannes Roth","family":"Madsen","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine Department of Clinical Immunology, Section 7631, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Hartwell","family":"Garred","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine Department of Clinical Immunology, Section 7631, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Jarlhelt","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine Department of Clinical Immunology, Section 7631, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille Brok","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Cardiology Herlev and Gentofte Hospital  Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffan Svejgaard","family":"Petersen","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S  M\u00e5l\u00f8v Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Gands\u00f8","family":"Fjordager","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S  M\u00e5l\u00f8v Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara T\u00f8lb\u00f8ll","family":"Lauritsen","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S  M\u00e5l\u00f8v Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Hilsted","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry Rigshospitalet, Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"Boding","sequence":"additional","affiliation":[{"name":"The National Biobank Statens Serum Institut  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0504-8487","authenticated-orcid":false,"given":"Kasper Karmark","family":"Iversen","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Cardiology Herlev and Gentofte Hospital  Herlev Denmark"},{"name":"Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liselotte","family":"Hyveled","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S  S\u00f8borg Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2876-8586","authenticated-orcid":false,"given":"Peter","family":"Garred","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Medicine Department of Clinical Immunology, Section 7631, Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"},{"name":"Department of Clinical Medicine Faculty of Health and Medical Sciences University of Copenhagen  Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"WHO.Coronavirus disease 2019 (COVID\u201019) situation report\u201451.2020. Available from:https:\/\/www.who.int\/docs\/default\u2010source\/coronaviruse\/situation\u2010reports\/20200311\u2010sitrep\u201051\u2010covid\u201019.pdf?sfvrsn=1ba62e57_10."},{"key":"e_1_2_10_3_1","unstructured":"WHO.2020.Who\u2010director\u2010general\u2010s\u2010opening\u2010remarks\u2010at\u2010the\u2010media\u2010briefing\u2010on\u2010covid\u201019\u201411\u2010march\u20102020. Available from:https:\/\/www.who.int\/director\u2010general\/speeches\/detail\/."},{"key":"e_1_2_10_4_1","unstructured":"The Danish Health Authority.Current data on the development of coronavirus.2021. Available from:https:\/\/www.sst.dk\/en\/English\/Corona\u2010eng\/Status\u2010of\u2010the\u2010epidemic\/COVID\u201019\u2010updates\u2010Statistics\u2010and\u2010charts."},{"key":"e_1_2_10_5_1","unstructured":"Danske Regioner.The Danish COVID\u201019 vaccination programme. Available from:https:\/\/www.regioner.dk\/sundhed\/coronaviruscovid\u201019\/vaccination\u2010mod\u2010covid\u201019\/the\u2010danish\u2010covid\u201019\u2010vaccination\u2010programme."},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30589-2"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07102-1"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243358"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19116783"},{"key":"e_1_2_10_10_1","unstructured":"The Novo Group (Novo Nordisk). Available from:https:\/\/www.novonordisk.com\/about\/who\u2010we\u2010are.html."},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000898"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29225-4"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.01330-21"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00796-8"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa849"},{"key":"e_1_2_10_17_1","unstructured":"The National COVID\u201019 Prevalence Study.Statens Serum Institut (SSI). Available from:https:\/\/covid19.ssi.dk\/overvagningsdata\/undersoegelser\/praevalensundersogelsen."},{"key":"e_1_2_10_18_1","unstructured":"Surveillance data for COVID\u201019 in Denmark and Europe.Statens Serum Institut (SSI). Available from:https:\/\/covid19.ssi.dk\/overvagningsdata."},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.011"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252617"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00026-7"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac194"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244126"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe0367"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03207-w"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101174"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.03.015"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050696"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118946"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13366"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1898291"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32656-8"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1792"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01292-y"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005427"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02537-22"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1648"},{"key":"e_1_2_10_38_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068302","article-title":"Effectiveness of public health measures in reducing the incidence of covid\u201019, SARS\u2010CoV\u20102 transmission, and Covid\u201019 mortality: systematic review and meta\u2010analysis","volume":"375","author":"Talic S","year":"2021","journal-title":"BMJ."},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13642-7"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.31756"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab100"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe3261"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.13637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T16:41:38Z","timestamp":1692463298000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.13637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1111\/joim.13637"],"URL":"https:\/\/doi.org\/10.1111\/joim.13637","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"2023-04-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}